Illumina DMA
As of date:2/6/2023
ILMN stock price:208.70
ILMN 50 DMA:206.68
ILMN 200 DMA:215.56
ILMN MACD (200-50):8.88

Also see:
ILMN Market Cap History
ILMN Shares Outstanding History
ILMN YTD Return
ILMN RSI
ILMN MACD
ILMN Technical Analysis

Trupanion (TRUP) Shares Cross Below 200 DMA
1 hour, 20 minutes ago


CHS Breaks Below 200-Day Moving Average - Notable for CHSCM
1 hour, 20 minutes ago


NUVA Makes Notable Cross Below Critical Moving Average
1 hour, 23 minutes ago


PRTS Crosses Below Key Moving Average Level
1 hour, 23 minutes ago


Mesa Laboratories (MLAB) Shares Cross Below 200 DMA
1 hour, 30 minutes ago


Notable Two Hundred Day Moving Average Cross - ENFN
1 hour, 36 minutes ago


BlackRock Municipal Target Term Trust Breaks Below 200-Day Moving Average - Notable for BTT
1 hour, 43 minutes ago


First Trust Dorsey Wright Dynamic Focus 5 (FVC) Shares Cross Below 200 DMA
1 hour, 43 minutes ago


FCTR Crosses Below Key Moving Average Level
1 hour, 56 minutes ago


Notable Two Hundred Day Moving Average Cross - AVY
1 hour, 56 minutes ago


Cohen & Steers Total Return Realty Fund (RFI) Shares Cross Below 200 DMA
1 hour, 56 minutes ago


Notable Two Hundred Day Moving Average Cross - VBND
2 hours ago


Loblaw Companies (L.CA) Shares Cross Above 200 DMA
2 hours, 4 minutes ago


Sonos Inc Breaks Below 200-Day Moving Average - Notable for SONO
4 hours, 28 minutes ago


The Trade Desk Breaks Below 200-Day Moving Average - Notable for TTD
4 hours, 30 minutes ago


More Technical Analysis News

ILMN DMAILMN MACD
Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co.'s products and services enable the adoption of genomic solutions in research and clinical settings. Co.'s principal products, services, and technologies are: sequencing, which includes Deoxyribonucleic acid (DNA) sequencing, a process of determining the order of nucleotide bases (A, C, G, or T) in a DNA sample; arrays, which are used for a range of DNA and RNA analysis applications; consumables, which Co. has developed various library preparation and sequencing kits; and services, which provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.

When researching a stock like Illumina, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from ILMN Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for ILMN stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the ILMN 200 day moving average ("ILMN 200 DMA"), while one of the most popular "shorter look-backs" is the ILMN 50 day moving average ("ILMN 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Illumina.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes

Email EnvelopeFree ILMN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Illumina (ILMN) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

INCY DMA
IQV DMA
ISRG DMA
JNJ DMA
LH DMA
LLY DMA
MCK DMA
MDT DMA
MMM DMA
MOH DMA
More Healthcare companies »

 

Illumina DMA | www.StockDMA.com | Copyright © 2019 - 2023, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.